Adverse effects of danazol prophylaxis on the lipid profiles of patients with hereditary angioedema

Journal of Allergy and Clinical Immunology

Volumn 115, Issue 4, 2005, Pages 864-869

  Széplaki, Gábor ^a   Varga, Lilian ^a   Valentin, Szilvia ^a   Kleiber, Mónika ^a   Karádi, István ^a   Romics, László ^a   Füst, George ^a   Farkas, Henriette ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Adverse effects; Atherosclerosis; Danazol; Hereditary angioedema; High density lipoprotein; Lipids; Low density lipoprotein

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B100; CHOLESTEROL; DANAZOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ANGIONEUROTIC EDEMA; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENETIC DISORDER; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MONITORING; PRIORITY JOURNAL; PROPHYLAXIS; RISK ASSESSMENT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 16244384459     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2004.12.1130     Document Type: Article

References (32)

1. H. Quincke Über akutes umschreibenes Hautödem Monatsschr Prakt Dermat 1 1882 129
2. W. Osler Hereditary angio-neurotic oedema Am J Med Sci 95 1888 362 367
3. A. Carugati, E. Pappalardo, L.C. Zingale, and M. Cicardi C1-inhibitor deficiency and angioedema Mol Immunol 38 2001 161 173
4. A. Agostoni, E. Aygören-Pürsün, K.E. Binkley, A. Blanch, K. Bork, and L. Bouillet Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond J Allergy Clin Immunol 114 suppl 3 2004 S51 S131
5. T. Bowen, M. Cicardi, H. Farkas, K. Bork, W. Kreuz, and L. Zingale Canadian 2003 international consensus algorithm for the diagnosis, therapy, and management of hereditary angioedema J Allergy Clin Immunol 114 2004 629 637
6. H. Farkas, L. Gyeney, E. Gidofalvy, G. Füst, and L. Varga The efficacy of short-term danazol prophylaxis in hereditary angioedema patients undergoing maxillofacial and dental procedures J Oral Maxillofac Surg 57 1999 404 408
7. J.A. Gelfand, R.J. Sherins, D.W. Alling, and M.M. Frank Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities N Engl J Med 295 1976 1444 1448
8. M. Cicardi, R. Castelli, L.C. Zingale, and A. Agostoni Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients J Allergy Clin Immunol 99 1997 194 196
9. S.W. Hosea, M.L. Santaella, E.J. Brown, M. Berger, K. Katusha, and M.M. Frank Long-term therapy of hereditary angioedema with danazol Ann Intern Med 93 1980 809 812
10. M. Cicardi, L. Bergamaschini, A. Tucci, A. Agostoni, G. Tornaghi, and G. Coggi Morphologic evaluation of the liver in hereditary angioedema patients on long-term treatment with androgen derivates J Allergy Clin Immunol 72 1983 294 298
11. G.L. Andriole, C. Brickman, E.E. Lack, I.A. Sesterhenn, N. Javadpour, and W.M. Linehan Danazol-induced cystitis: an undescribed source of hematuria in patients with hereditary angioneurotic edema J Urol 135 1986 44 46
12. J.J. Zurlo, and M.M. Frank The long-term safety of danazol in women with hereditary angioedema Fertil Steril 54 1990 64 72
13. M. Cicardi, L. Bergamaschini, M. Cugno, E. Hack, G. Agostoni, and A. Agostoni Long-term treatment of hereditary angioedema with attenuated androgens: a survey of a 13-year experience J Allergy Clin Immunol 87 1991 768 773
14. K. Bork, M. Pitton, P. Harten, and P. Koch Hepatocellular adenomas in patients taking danazol for hereditary angio-oedema Lancet 353 1999 1066 1067
15. K. Bork, and V. Schneiders Danazol-induced hepatocellular adenoma in patients with hereditary angio-oedema J Hepatol 36 2002 707 709
16. N. Hoogerbrugge, H. Jansen, and J.C. Birkenhäger Danazol in the treatment of endometriosis and hereditary angio-oedema J Intern Med 237 1995 603 605
17. A.A. Luciano, R.B. Wallace, and B.M. Sherman Effect of danazol on plasma lipid and lipoprotein levels in normal women Atherosclerosis 43 1982 133 137
18. D. Crook, M. Sidhu, M. Seed, M. O'Donnell, and J.C. Stevenson Lipoprotein Lp(a) levels are reduced by danazol, an anabolic steroid Atherosclerosis 92 1992 41 47
19. C.J. Packard, and J. Shepherd Action of danazol on plasma lipids and lipoprotein metabolism Acta Obstet Gynecol Scand Suppl 159 1994 35 40
20. J. Shepherd Danazol and plasma lipoprotein metabolism Int J Gynaecol Obstet 50 suppl 1 1995 S23 S26
21. H. Farkas, and L. Varga The Hungarian HAE experience Transfus Apheresis Sci 29 2003 229 233
22. L. Kalmár, A. Bors, H. Farkas, S. Vas, B. Fandl, and L. Varga Mutation screening of the C1 inhibitor gene among Hungarian patients with hereditary angioedema Hum Mutat 22 2003 498
23. H. Farkas, G. Harmat, G. Füst, L. Varga, and B. Visy Clinical management of hereditary angio-edema in children Pediatr Allergy Immunol 13 2002 153 161
24. W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge Clin Chem 18 1972 499 502
25. Á Kalina, A. Császár, G. Füst, B. Nagy, C. Szalai, and I. Karádi The association of serum lipoprotein(a) levels, apolipoprotein(a) size and (TTTTA)(n) polymorphism with coronary heart disease Clin Chim Acta 309 2001 45 51
26. H. Dieplinger, G. Gruber, K. Krasznai, S. Reschauer, C. Seidel, and G. Burns Kringle 4 of human apolipoprotein[a] shares a linear antigenic site with human catalase J Lipid Res 36 1995 813 822
27. A.K. Mantel-Teeuwisse, J.M. Kloosterman, A.H. Maitland-van der Zee, O.H. Klungel, A.J. Porsius, and A. de Boer Drug-induced lipid changes: a review of the unintended effects of some commonly used drugs on serum lipid levels Drug Saf 24 2001 443 456
28. A.M. Scanu, R.M. Lawn, and K. Berg Lipoprotein(a) and atherosclerosis Ann Intern Med 115 1991 209 218
29. G.H. Dahlen Lp(a) lipoprotein in cardiovascular disease Atherosclerosis 108 1994 111 126
30. D. Crook, R. Howell, M. Sidhu, D.K. Edmonds, and J.C. Stevenson Elevated serum lipoprotein(a) levels in young women with endometriosis Metabolism 46 1997 735 739
31. I. Ford, T.C. Li, I.D. Cooke, and F.E. Preston Changes in haematological indices, blood viscosity and inhibitors of coagulation during the treatment of endometriosis with danazol Thromb Haemost 72 1994 218 221
32. R. Oksjoki, P.T. Kovanen, and M.O. Pentikainen Role of complement activation in atherosclerosis Curr Opin Lipidol 14 2003 477 482